PDF herunterladen
Thorac Cardiovasc Surg 2022; 70(02): 093-099
DOI: 10.1055/s-0040-1716324
Original Cardiovascular

Long-Term Clinical Outcome in Elderly Patients Undergoing Mitral Valve Repair

Julia Götte
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Armin Zittermann
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Kavous Hakim-Meibodi
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Masatoshi Hata
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Rene Schramm
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Sabine Bleiziffer
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Mohammed Amin Parsa
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Jan Gummert
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
,
Andre Renner
1   Department of Cardio-Thoracic Surgery, Heart and Diabetes Center North Rhine Westphalia, Bad Oeynhausen, Nordrhein-Westfalen, 32545, Germany
› Institutsangaben Funding None.
› Weitere Informationen
    Lizenzen und Reprints Alle Artikel dieser Rubrik

Abstract

Background Long-term data on patients over 75 years undergoing mitral valve (MV) repair are scarce. At our high-volume institution, we, therefore, aimed to evaluate mortality, stroke risk, and reoperation rates in these patients.

Methods We investigated clinical outcomes in 372 patients undergoing MV repair with (n = 115) or without (n = 257) tricuspid valve repair. The primary endpoint was the probability of survival up to a maximum follow-up of 9 years. Secondary clinical endpoints were stroke and reoperation of the MV during follow-up. Univariate and multivariable Cox regression analysis was performed to assess independent predictors of mortality. Mortality was also compared with the age- and sex-adjusted general population.

Results During a median follow-up period of 37 months (range: 0.1–108 months), 90 patients died. The following parameters were independently associated with mortality: double valve repair (hazard ratio, confidence interval [HR, 95% CI]: 2.15, 1.37–3.36), advanced age (HR: 1.07, CI: 1.01–1.14 per year), diabetes (HR: 1.97, CI: 1.13–3.43), preoperative New York Heart Association (NYHA) functional class (HR: 1.41, CI: 1.01–1.97 per class), and operative creatininemax levels (HR: 1.32, CI: 1.13–1.55 per mg/dL). The risk of stroke in the isolated MV and double valve repair groups at postoperative year 5 was 5.0 and 4.1%, respectively (p = 0.65). The corresponding values for the risk of reoperation were 4.0 and 7.0%, respectively (p = 0.36). Nine-year survival was comparable with the general population (53.2 vs. 53.1%).

Conclusion Various independent risk factors for mortality in elderly MV repair patients could be identified, but overall survival rates were similar to those of the general population. Consequently, our data indicates that repairing the MV in elderly patients represents a suitable and safe surgical approach.

Keywords

mitral valve - tricuspid valve - valve repair - mortality - age

Author Contribution

Study concept and design: JG and AR.


Acquisition, analysis, or interpretation of data: JG, AZ, KHM, MH, RS, SB, MAP, JFG, AR.


Drafting of the manuscript: JG and AZ.


Critical revision for important intellectual content: SB, AR.


Statistical analysis: AZ.


Administrative, technical, or material support: KHM, MH, RS, SB, MAP, JFG.


Study supervision: JFG and AR.


Final approval of the version to be published: all authors.




Publikationsverlauf

Eingereicht: 03. März 2020

Angenommen: 13. Juli 2020

Artikel online veröffentlicht:
30. September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Gammie JS, Sheng S, Griffith BP. et al. Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg 2009; 87 (05) 1431-1437 , discussion 1437–1439
    CrossrefPubMedGoogle Scholar
  • 2 Ailawadi G, Swenson BR, Girotti ME. et al. Is mitral valve repair superior to replacement in elderly patients?. Ann Thorac Surg 2008; 86 (01) 77-85 , discussion 86
    CrossrefPubMedGoogle Scholar
  • 3 Badhwar V, Peterson ED, Jacobs JP. et al. Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. Ann Thorac Surg 2012; 94 (06) 1870-1877 , discussion 1877–1879
    CrossrefPubMedGoogle Scholar
  • 4 Silaschi M, Chaubey S, Aldalati O. et al. Is mitral valve repair superior to mitral valve replacement in elderly patients? Comparison of short- and long-term outcomes in a propensity-matched cohort. J Am Heart Assoc 2016; 5 (08) e003605
    CrossrefPubMedGoogle Scholar
  • 5 Seeburger J, Falk V, Garbade J. et al. Mitral valve surgical procedures in the elderly. Ann Thorac Surg 2012; 94 (06) 1999-2003
    CrossrefPubMedGoogle Scholar
  • 6 Shuhaiber J, Anderson RJ. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg 2007; 31 (02) 267-275
    CrossrefPubMedGoogle Scholar
  • 7 Chan V, Ruel M, Mesana TG. Mitral valve replacement is a viable alternative to mitral valve repair for ischemic mitral regurgitation: a case-matched study. Ann Thorac Surg 2011; 92 (04) 1358-1365 , discussion 1365–1366
    CrossrefPubMedGoogle Scholar
  • 8 Feldman T, Kar S, Rinaldi M. et al. EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009; 54 (08) 686-694
    CrossrefPubMedGoogle Scholar
  • 9 Beckmann A, Meyer R, Lewandowski J, Frie M, Markewitz A, Harringer W. German Heart Surgery Report 2017: the Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2018; 66 (08) 608-621
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 10 Feldman T, Kar S, Elmariah S. et al. EVEREST II Investigators. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 2015; 66 (25) 2844-2854
    CrossrefPubMedGoogle Scholar
  • 11 Seeburger J, Katus HA, Pleger ST, Krumsdorf U, Mohr FW, Bekeredjian R. Percutaneous and surgical treatment of mitral valve regurgitation. Dtsch Arztebl Int 2011; 108 (48) 816-821
    PubMedGoogle Scholar
  • 12 Renner A, Zittermann A, Aboud A, Hakim-Meibodi K, Börgermann J, Gummert JF. Early and mid-term clinical outcome in younger and elderly patients undergoing mitral valve repair with or without tricuspid valve repair. Interact Cardiovasc Thorac Surg 2015; 20 (01) 85-89
    CrossrefPubMedGoogle Scholar
  • 13 Torpy JM, Lynm C, Glass RM. JAMA patient page. Frailty in older adults. JAMA 2006; 296 (18) 2280
    CrossrefPubMedGoogle Scholar
  • 14 Harrell Jr FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15 (04) 361-387
    CrossrefPubMedGoogle Scholar
  • 15 Statistical Yearbook for the Federal Republic of Germany. Published by Federal Statistical Office, Destatis. Westermann Druck Zwickau GmbH; 2018: 40-41
    Google Scholar
  • 16 Grossi EA, Zakow PK, Sussman M. et al. Late results of mitral valve reconstruction in the elderly. Ann Thorac Surg 2000; 70 (04) 1224-1226
    CrossrefPubMedGoogle Scholar
  • 17 Daneshmand MA, Milano CA, Rankin JS. et al. Influence of patient age on procedural selection in mitral valve surgery. Ann Thorac Surg 2010; 90 (05) 1479-1485 , discussion 1485–1486
    CrossrefPubMedGoogle Scholar
  • 18 Gaur P, Kaneko T, McGurk S, Rawn JD, Maloney A, Cohn LH. Mitral valve repair versus replacement in the elderly: short-term and long-term outcomes. J Thorac Cardiovasc Surg 2014; 148 (04) 1400-1406
    CrossrefPubMedGoogle Scholar
  • 19 David TE, Armstrong S, McCrindle BW, Manlhiot C. Late outcomes of mitral valve repair for mitral regurgitation due to degenerative disease. Circulation 2013; 127 (14) 1485-1492
    CrossrefPubMedGoogle Scholar
  • 20 Volkert D, Kreuel K, Stehle P. [“Nutrition beyond 65”--amount of usual drinking fluid and motivation to drink are interrelated in community-living, independent elderly people]. Z Gerontol Geriatr 2004; 37 (06) 436-443 [in German]
    CrossrefPubMedGoogle Scholar
  • 21 Gillinov AM, Cosgrove DM, Blackstone EH. et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998; 116 (05) 734-743
    CrossrefPubMedGoogle Scholar
  • 22 Gillinov AM, Blackstone EH, Nowicki ER. et al. Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg 2008; 135 (04) 885-893 , 893.e1–893.e2
    CrossrefPubMedGoogle Scholar
  • 23 Maisano F, Taramasso M, Nickenig G. et al. Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J 2016; 37 (10) 817-825
    CrossrefPubMedGoogle Scholar